Abstract:Background Triple-negative breast cancer (TNBC) is a category of breast cancer characterized with high molecular heterogeneity. Owing to the lack of effective therapeutic strategies, patients with TNBC have a poor prognosis. Paris saponin VII (PSVII), a steroidal saponin extracted from the rhizome of Trichillium tschonoskii Maxim, exhibits excellent anti-cancer activity in a variety of solid tumors. However, the role and potential mechanism of PSVII against TNBC remain unexplored. Purpose This study aimed to elucidate the therapeutic effects of PSVII against TNBC and explore the potential mechanism of action. Methods We combined the analysis of public single-cell sequencing data with weighted gene co-expression network analysis (WGCNA) to identity differentially expressed genes (DEGs) that distinguished malignant and normal epithelial cells in TNBC. Subsequently, the biological features of DEGs in TNBC were evaluated. Gene set enrichment analysis (GSEA) was used to define potential pathways associated with the DEGs. The pharmacological activity of PSVII for TNBC was evidenced via in vitro and in vivo experiments, and molecular docking, molecular dynamics (MD), surface plasmon resonance (SPR) assay and western blotting were employed to confirm the relative mechanisms. Results Single-cell sequencing and WGCNA revealed STMN1 as a pivotal biomarker of TNBC. STMN1 overexpression in TNBC was associated with poor patient prognosis. GSEA revealed a significant accumulation of STMN1 within the MAPK signaling pathway. Furthermore, In vitro experiments showed that PSVII showed significantly suppressive actions on the proliferation, migration and invasion abilities for TNBC cells, while inducing apoptosis. Molecular docking, MD analysis and SPR assay indicated a robust interaction between PSVII and the MEK protein. Western blotting revealed that PSVII may inhibit tumor progression by suppressing the phosphorylation of MEK1/2 and the downstream phosphorylation of ERK1/2 and STMN1. Intraperitoneal injection of PSVII (10 mg/kg) notably reduced tumor growth by 71.26 % in a 4T1 xenograft model. Conclusion In our study, the systems biology method was used to identify potential therapeutic targets for TNBC. In vitro and in vivo experiments demonstrated PSVII suppresses cancer progression by targeting the MEK/ERK/STMN1 signaling axis. For the first time, the inhibition of STMN1 phosphorylation has been indicated as a possible mechanism for the anticancer effects of PSVII. These results emphasize the potential value of PSVII as a promising anti-cancer drug candidate for further development in the field of TNBC therapeutics.

Paris Polyphylla -Derived Saponins Inhibit Growth of Bladder Cancer Cells by Inducing Mutant P53 Degradation While Up-Regulating CDKN1A Expression.

Paris Saponin VII Reverses Chemoresistance in Breast MCF-7/ADR Cells.

Prodelphinidins Isolated from Chinese Bayberry Leaves Induces Apoptosis Via the P53-Dependent Signaling Pathways in OVCAR-3 Human Ovarian Cancer Cells

Effects of Pennogenin 3-O-<i>β</i>-Chacotrioside, a Steroidal Saponin from <i>Rhizoma paridis</i>, on Proliferation Inhibition and Apoptosis Induction in Non-Small Cell Lung Cancer Cells

Echinatin Inhibits Tumor Growth and Synergizes with Chemotherapeutic Agents Against Human Bladder Cancer Cells by Activating P38 and Suppressing Wnt/β-catenin Pathways

Purple sweet potato anthocyanin exerts antitumor effect in bladder cancer

Paris saponin VII, a Hippo pathway activator, induces autophagy and exhibits therapeutic potential against human breast cancer cells

The Extract of Paris Polyphylla Exerts Apoptotic Induction and Synergic Antiproliferative Effect with Anticancer Drugs in SMMC-7721 Human Liver Cancer Cells

Paris Saponin I Induces Apoptosis Via Increasing the Bax/Bcl-2 Ratio and Caspase-3 Expression in Gefitinib-Resistant Non-Small Cell Lung Cancer in Vitro and in Vivo.

Effects of Polyphyllin I on Growth Inhibition of Human Non-Small Lung Cancer Cells and in Xenograft

The Combinatory Effects Of Ppar-Gamma Agonist And Survivin Inhibition On The Cancer Stem-Like Phenotype And Cell Proliferation In Bladder Cancer Cells

Parthenolide Induces Apoptosis And Cell Cycle Arrest Of Human 5637 Bladder Cancer Cells In Vitro

Paris saponin VII inhibits triple-negative breast cancer by targeting the MEK/ERK/STMN1 signaling axis

Prevention of hip fractures: risk factor modification.

Mechanism of Paris polyphylla saponin II inducing autophagic to inhibit angiogenesis of cervical cancer

Convolution theorem for nonlinear optics

Research progress of Paris polyphylla in the treatment of digestive tract cancers

A tumor targeted nano micelle carrying astragaloside IV for combination treatment of bladder cancer

The Chinese herb polyphyllin D sensitizes ovarian cancer cells to cisplatin-induced growth arrest

Paris Polyphylla Suppresses Proliferation and Vasculogenic Mimicry of Human Osteosarcoma Cells and Inhibits Tumor Growth in Vivo.

Proteomics Analysis of Polyphyllin D-Treated Triple-Negative Breast Cancer Cells Reveal the Anticancer Mechanisms of Polyphyllin D